CL2019001750A1 - Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas. - Google Patents
Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas.Info
- Publication number
- CL2019001750A1 CL2019001750A1 CL2019001750A CL2019001750A CL2019001750A1 CL 2019001750 A1 CL2019001750 A1 CL 2019001750A1 CL 2019001750 A CL2019001750 A CL 2019001750A CL 2019001750 A CL2019001750 A CL 2019001750A CL 2019001750 A1 CL2019001750 A1 CL 2019001750A1
- Authority
- CL
- Chile
- Prior art keywords
- disease
- protein aggregation
- french
- modulators
- heteroaryl derivatives
- Prior art date
Links
- 230000004845 protein aggregation Effects 0.000 title abstract 2
- 125000003545 alkoxy group Chemical group 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 208000018737 Parkinson disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000001089 Multiple system atrophy Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A CIERTOS COMPUESTOS DE BISHETEROARILO, A LAS COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y A LOS MÉTODOS PARA USARLOS, INCLUIDOS LOS MÉTODOS PARA PREVENIR, REVERTIR, DESACELERAR O INHIBIR LA AGREGACIÓN DE PROTEÍNAS, Y A LOS MÉTODOS PARA TRATAR ENFERMEDADES QUE ESTÁN ASOCIADAS CON LA AGREGACIÓN DE PROTEÍNAS, INCLUYENDO LAS ENFERMEDADES NEURODEGENERATIVAS TALES COMO LA ENFERMEDAD DE PARKINSON, LA ENFERMEDAD DE ALZHEIMER, LA ENFERMEDAD DE LOS CUERPOS DE LEWY, LA ENFERMEDAD DE PARKINSON CON DEMENCIA, LA DEMENCIA FRONTO-TEMPORAL, LA ENFERMEDAD DE HUNTINGTON, LA ESCLEROSIS LATERAL AMIOTRÓFICA, LA ATROFIA MULTISISTÉMICA Y EL CÁNCER, INCLUIDO EL MELANOMA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17153210 | 2017-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2019001750A1 true CL2019001750A1 (es) | 2019-11-22 |
Family
ID=57906525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019001750A CL2019001750A1 (es) | 2017-01-26 | 2019-06-21 | Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11091474B2 (es) |
| EP (1) | EP3573981B1 (es) |
| JP (1) | JP7100042B2 (es) |
| KR (1) | KR20190112031A (es) |
| CN (1) | CN110191885B (es) |
| AU (1) | AU2018213886A1 (es) |
| BR (1) | BR112019011931A2 (es) |
| CA (1) | CA3048946A1 (es) |
| CL (1) | CL2019001750A1 (es) |
| CO (1) | CO2019007833A2 (es) |
| EA (1) | EA201991753A1 (es) |
| ES (1) | ES2918048T3 (es) |
| IL (1) | IL268003A (es) |
| MA (1) | MA47369A (es) |
| MX (1) | MX2019007054A (es) |
| RU (1) | RU2019126164A (es) |
| WO (1) | WO2018138085A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019126170A (ru) * | 2017-01-26 | 2021-02-26 | Юсб Байофарма Спрл | Бисгетероарильные производные в качестве модуляторов агрегации белков |
| CN113214289B (zh) * | 2020-01-21 | 2022-10-28 | 瀚远医药有限公司 | 5-ht2a受体拮抗剂及其治疗中枢神经系统疾病的应用 |
| WO2023125376A1 (zh) * | 2021-12-27 | 2023-07-06 | 上海京新生物医药有限公司 | 作为蛋白质聚集抑制剂的稠合双环杂芳基酰胺化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0910003D0 (en) | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| MX335989B (es) * | 2009-12-16 | 2016-01-07 | Neuropore Therapies Inc | Compuesto adecuado para el tratamiento de sinucleopatias. |
| GB201021103D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | New compounds for the treatment of neurodegenerative diseases |
| WO2013134371A1 (en) | 2012-03-06 | 2013-09-12 | Neuropore Therapies, Inc. | Methods and compounds to be used in the treatment of neurodegenerative diseases |
| EP2830608B8 (en) | 2012-03-28 | 2020-01-15 | UCB Biopharma SRL | Phenyl-urea and phenyl-carbamate derivatives as inhibitors of protein aggregation |
| ES2661394T3 (es) * | 2012-07-16 | 2018-03-28 | Neuropore Therapies, Inc. | Derivados de di- y tri-heteroarilo como inhibidores de la agregación de proteínas |
| DK3348556T3 (da) * | 2014-01-29 | 2020-08-03 | UCB Biopharma SRL | Heteroarylamider som hæmmere af proteinaggregering |
| ES2885049T3 (es) | 2015-07-29 | 2021-12-13 | UCB Biopharma SRL | Derivados de bis-heteroarilo como moduladores de la agregación de proteínas |
| RU2019126170A (ru) * | 2017-01-26 | 2021-02-26 | Юсб Байофарма Спрл | Бисгетероарильные производные в качестве модуляторов агрегации белков |
| CN110167937B (zh) | 2017-01-26 | 2022-03-29 | Ucb生物制药私人有限公司 | 作为蛋白质聚集调节剂的二环双-杂芳基衍生物 |
-
2018
- 2018-01-23 ES ES18703235T patent/ES2918048T3/es active Active
- 2018-01-23 BR BR112019011931-0A patent/BR112019011931A2/pt not_active Application Discontinuation
- 2018-01-23 MA MA047369A patent/MA47369A/fr unknown
- 2018-01-23 AU AU2018213886A patent/AU2018213886A1/en not_active Abandoned
- 2018-01-23 RU RU2019126164A patent/RU2019126164A/ru not_active Application Discontinuation
- 2018-01-23 KR KR1020197024618A patent/KR20190112031A/ko not_active Application Discontinuation
- 2018-01-23 EP EP18703235.4A patent/EP3573981B1/en active Active
- 2018-01-23 US US16/480,251 patent/US11091474B2/en active Active
- 2018-01-23 WO PCT/EP2018/051579 patent/WO2018138085A1/en unknown
- 2018-01-23 JP JP2019539261A patent/JP7100042B2/ja active Active
- 2018-01-23 EA EA201991753A patent/EA201991753A1/ru unknown
- 2018-01-23 CA CA3048946A patent/CA3048946A1/en active Pending
- 2018-01-23 MX MX2019007054A patent/MX2019007054A/es unknown
- 2018-01-23 CN CN201880006709.9A patent/CN110191885B/zh active Active
-
2019
- 2019-06-21 CL CL2019001750A patent/CL2019001750A1/es unknown
- 2019-07-11 IL IL268003A patent/IL268003A/en unknown
- 2019-07-22 CO CONC2019/0007833A patent/CO2019007833A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190112031A (ko) | 2019-10-02 |
| AU2018213886A1 (en) | 2019-07-25 |
| CA3048946A1 (en) | 2018-08-02 |
| EP3573981A1 (en) | 2019-12-04 |
| EA201991753A1 (ru) | 2020-01-14 |
| BR112019011931A2 (pt) | 2019-10-29 |
| MX2019007054A (es) | 2019-08-29 |
| EP3573981B1 (en) | 2022-03-16 |
| CN110191885A (zh) | 2019-08-30 |
| MA47369A (fr) | 2019-12-04 |
| IL268003A (en) | 2019-09-26 |
| WO2018138085A1 (en) | 2018-08-02 |
| ES2918048T3 (es) | 2022-07-13 |
| JP2020505368A (ja) | 2020-02-20 |
| US20200291013A1 (en) | 2020-09-17 |
| US11091474B2 (en) | 2021-08-17 |
| JP7100042B2 (ja) | 2022-07-12 |
| CO2019007833A2 (es) | 2019-08-20 |
| CN110191885B (zh) | 2023-05-16 |
| RU2019126164A (ru) | 2021-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019007830A2 (es) | Derivados de bis-heteroarilo bicíclicos como moduladores de agregación de proteínas | |
| CO2019007835A2 (es) | Derivados de bis-heteroarilo como moduladores de la agregación de proteínas | |
| CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
| CR20160394A (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
| CL2019001744A1 (es) | Derivados de benzoxazol como inmunomoduladores. | |
| GT201600147A (es) | Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2 | |
| CO2017012995A2 (es) | Derivados análogos de heteroarilos/arilo actvos como reguladores nrf2 y composiciones farmacéuticas de los mismos | |
| ECSP20033467A (es) | Compuestos macrocíclicos para tratar enfermedades | |
| UY36077A (es) | Derivados de 6-amino-8h-pteridin-7-ona como moduladores de ror gamma y composiciones farmacéuticas que los contienen | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| CU20170172A7 (es) | 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos | |
| CL2017003127A1 (es) | Derivados de 2,3-dihidro-4h-1,3-benzoxazin-4-ona como moduladores de receptor muscarinico m1 colinergico. | |
| DOP2018000204A (es) | Moduladores alostéricos de receptores de acetilcolina nicotínicos | |
| CL2019001750A1 (es) | Derivados de alcoxi bis-heteroarilo como moduladores de la agregación de proteínas. | |
| CL2016002346A1 (es) | Composiciones para modular la expresión de ataxina 2 | |
| DOP2017000117A (es) | 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
| CL2017001073A1 (es) | 2,4 diamino-quinolia sustituido como nuevos agentes anticancerigenos | |
| UY36178A (es) | Novedosos derivados de ácido heteroaril-butanoico | |
| UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
| CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
| CL2016002677A1 (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1. | |
| CL2017000244A1 (es) | Formulaciones de compuestos biológicos para instilación intravesical. | |
| CO2019003255A2 (es) | Composición que comprende una combinación de un anáologo de trh con ácido arúndico y una sal farmacéuticamente aceptable de ácido arúndico | |
| CL2015003460A1 (es) | Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica |